所有地区都能通行吗？市场准入和卫生技术评估方面的发展综述：第8部分。

IF 1.9 4区医学 Q3 HEALTH CARE SCIENCES & SERVICES

Journal of comparative effectiveness research Pub Date : 2025-06-17 DOI:10.57264/cer-2025-0091

Sreeram V Ramagopalan, Annie Jullien Pannelay

引用次数: 0

摘要

在这篇更新中，我们讨论了卫生技术评估中联合疗法的定价悖论；研究通货膨胀减少法案对制药创新的影响，并分析修订后的荷兰经济评估准则。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Access in all areas? A round up of developments in market access and health technology assessment: part 8.

In this update, we discuss the pricing paradox of combination therapies in health technology assessment; examine the Inflation Reduction Act's impact on pharmaceutical innovation and analyze the revised Dutch economic evaluation guidelines.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of comparative effectiveness research HEALTH CARE SCIENCES & SERVICES-

CiteScore

3.50

自引率

9.50%

发文量

121

期刊介绍： Journal of Comparative Effectiveness Research provides a rapid-publication platform for debate, and for the presentation of new findings and research methodologies. Through rigorous evaluation and comprehensive coverage, the Journal of Comparative Effectiveness Research provides stakeholders (including patients, clinicians, healthcare purchasers, and health policy makers) with the key data and opinions to make informed and specific decisions on clinical practice.